Dopamine Dysregulation Syndrome in Parkinson's Disease Patients on Duodenal Levodopa Infusion

2013 ◽  
Vol 28 (6) ◽  
pp. 840-841 ◽  
Author(s):  
Antonino Cannas ◽  
Paolo Solla ◽  
Maria Giovanna Marrosu ◽  
Francesco Marrosu
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Dysregulation Syndrome ◽  
Duodenal Levodopa Infusion

Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson's disease

2016 ◽  
Vol 28 ◽  
pp. 152-154 ◽  
Author(s):  
Lucia Ricciardi ◽  
Kristy J. Espay ◽  
Robert Krikorian ◽  
Alfonso Fasano ◽  
Alberto J. Espay
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Dysregulation Syndrome

scholarly journals Neuropsychiatric symptoms in Parkinson's disease: aetiology, diagnosis and treatment

2020 ◽  
Vol 26 (6) ◽  
pp. 333-342 ◽  
Author(s):  
Shoned Jones ◽  
Kelli M. Torsney ◽  
Lily Scourfield ◽  
Katie Berryman ◽  
Emily J. Henderson
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Neuropsychiatric Symptoms ◽  
Treatment Strategies ◽  
Current Treatment ◽  
Motor Disorder ◽  
Dopamine Dysregulation Syndrome ◽  
Disease Aetiology ◽  
Neuropsychiatric Manifestations ◽  
Assessment Scales

SUMMARYHistorically, Parkinson's disease was viewed as a motor disorder and it is only in recent years that the spectrum of non-motor disorders associated with the condition has been fully recognised. There is a broad scope of neuropsychiatric manifestations, including depression, anxiety, apathy, psychosis and cognitive impairment. Patients are more predisposed to delirium, and Parkinson's disease treatments give rise to specific syndromes, including impulse control disorders, dopamine agonist withdrawal syndrome and dopamine dysregulation syndrome. This article gives a broad overview of the spectrum of these conditions, describes the association with severity of Parkinson's disease and the degree to which dopaminergic degeneration and/or treatment influence symptoms. We highlight useful assessment scales that inform diagnosis and current treatment strategies to ameliorate these troublesome symptoms, which frequently negatively affect quality of life.

Polyneuropathy while on duodenal levodopa infusion in Parkinson’s disease patients: we must be alert

2012 ◽  
Vol 259 (8) ◽  
pp. 1668-1672 ◽  
Author(s):  
Diego Santos-García ◽  
Raúl de la Fuente-Fernández ◽  
Francesc Valldeoriola ◽  
Antonio Palasí ◽  
Fátima Carrillo ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Duodenal Levodopa Infusion
Sign in / Sign up

Export Citation Format

Share Document